Table 2. Influenza A(H3N2) viruses characterised by clade, amino acid substitutions and study site, at nine participating laboratories, I-MOVE/I-MOVE+ primary care multicentre case control study, Europe, influenza season 2016/17 (n = 1,817).
| Characterised viruses (clade) | Germany n = 289 |
France n = 584 |
Hungary n = 39 |
Ireland n = 135 |
The Netherlands n = 47 |
Portugal n = 156 |
Romania n = 27 |
Spain n = 474 |
Sweden n = 66 |
Total n = 1,817 |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | |
| A/HongKong/4801/2014 (3C.2a) | 10 | 6 | 3 | 0 | 8 | 8 | 4 | 3 | 4 | 46 | ||||||||||
| N121K + S144K | 3 | 30 | 6 | 100 | 3 | 100 | 0 | 1 | 12 | 8 | 100 | 4 | 100 | 3 | 100 | 3 | 75 | 31 | 67 | |
| A/Bolzano/7/2016 (3C.2a1) | 33 | 19 | 3 | 5 | 20 | 23 | 8 | 36 | 9 | 156 | ||||||||||
| N171K + N121K + I140M | 10 | 30 | 0 | 0 | 0 | 7 | 35 | 2 | 9 | 4 | 50 | 8 | 22 | 3 | 33 | 34 | 22 | |||
| N171K + N121K + T135K | 2 | 6 | 0 | 2 | 67 | 0 | 3 | 15 | 0 | 0 | 1 | 3 | 3 | 33 | 11 | 7 | ||||
| N171K + N121K + K92R + H311Q | 8 | 24 | 0 | 1 | 33 | 1 | 20 | 4 | 20 | 4 | 17 | 0 | 10 | 28 | 0 | 28 | 18 | |||
| N171K + R142G | 7 | 21 | 3 | 16 | 0 | 3 | 60 | 3 | 15 | 17 | 74 | 0 | 1 | 3 | 1 | 11 | 35 | 22 | ||
| A/Switzerland/9715293/2013 (3C.3a) | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 2 | ||||||||||
| Total sequenced/total A(H3N2) | 43 | 15 | 25 | 4 | 6 | 15 | 7 | 5 | 28 | 60 | 31 | 20 | 12 | 44 | 39 | 8 | 13 | 20 | 204 | 11 |